Report Cover

Global and China Gene Therapies for Cancer Treatment Market Size, Status and Forecast 2021-2027


Global Gene Therapies for Cancer Treatment Scope and Market Size
Gene Therapies for Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapies for Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
    Somatic Cell Gene Therapy (SCGT)
    Germline Gene Therapy (GGT)

Segment by Application
    Cancer Research Centers
    Diagnostic Laboratories
    Cancer Hospitals
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

By Company
    Takara Bio
    Tocagen
    VBL Therapeutics
    Cold Genesys
    Genprex
    Momotaro-Gene
    MultiVir
    SynerGene Therapeutics
    Ziopharm Oncology
    Anchiano Therapeutics
    Celgene
    Celsion
    Bluebird Bio
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Somatic Cell Gene Therapy (SCGT)
        1.2.3 Germline Gene Therapy (GGT)
    1.3 Market by Application
        1.3.1 Global Gene Therapies for Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Cancer Research Centers
        1.3.3 Diagnostic Laboratories
        1.3.4 Cancer Hospitals
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Gene Therapies for Cancer Treatment Market Perspective (2016-2027)
    2.2 Gene Therapies for Cancer Treatment Growth Trends by Regions
        2.2.1 Gene Therapies for Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Gene Therapies for Cancer Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Gene Therapies for Cancer Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Gene Therapies for Cancer Treatment Industry Dynamic
        2.3.1 Gene Therapies for Cancer Treatment Market Trends
        2.3.2 Gene Therapies for Cancer Treatment Market Drivers
        2.3.3 Gene Therapies for Cancer Treatment Market Challenges
        2.3.4 Gene Therapies for Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue
        3.1.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue (2016-2021)
        3.1.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Gene Therapies for Cancer Treatment Revenue
    3.4 Global Gene Therapies for Cancer Treatment Market Concentration Ratio
        3.4.1 Global Gene Therapies for Cancer Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gene Therapies for Cancer Treatment Revenue in 2020
    3.5 Gene Therapies for Cancer Treatment Key Players Head office and Area Served
    3.6 Key Players Gene Therapies for Cancer Treatment Product Solution and Service
    3.7 Date of Enter into Gene Therapies for Cancer Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapies for Cancer Treatment Breakdown Data by Type
    4.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Gene Therapies for Cancer Treatment Breakdown Data by Application
    5.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Gene Therapies for Cancer Treatment Market Size (2016-2027)
    6.2 North America Gene Therapies for Cancer Treatment Market Size by Type
        6.2.1 North America Gene Therapies for Cancer Treatment Market Size by Type (2016-2021)
        6.2.2 North America Gene Therapies for Cancer Treatment Market Size by Type (2022-2027)
        6.2.3 North America Gene Therapies for Cancer Treatment Market Size by Type (2016-2027)
    6.3 North America Gene Therapies for Cancer Treatment Market Size by Application
        6.3.1 North America Gene Therapies for Cancer Treatment Market Size by Application (2016-2021)
        6.3.2 North America Gene Therapies for Cancer Treatment Market Size by Application (2022-2027)
        6.3.3 North America Gene Therapies for Cancer Treatment Market Size by Application (2016-2027)
    6.4 North America Gene Therapies for Cancer Treatment Market Size by Country
        6.4.1 North America Gene Therapies for Cancer Treatment Market Size by Country (2016-2021)
        6.4.2 North America Gene Therapies for Cancer Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Gene Therapies for Cancer Treatment Market Size (2016-2027)
    7.2 Europe Gene Therapies for Cancer Treatment Market Size by Type
        7.2.1 Europe Gene Therapies for Cancer Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Gene Therapies for Cancer Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Gene Therapies for Cancer Treatment Market Size by Type (2016-2027)
    7.3 Europe Gene Therapies for Cancer Treatment Market Size by Application
        7.3.1 Europe Gene Therapies for Cancer Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Gene Therapies for Cancer Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Gene Therapies for Cancer Treatment Market Size by Application (2016-2027)
    7.4 Europe Gene Therapies for Cancer Treatment Market Size by Country
        7.4.1 Europe Gene Therapies for Cancer Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Gene Therapies for Cancer Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Type
        8.2.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Application
        8.3.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region
        8.4.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Gene Therapies for Cancer Treatment Market Size (2016-2027)
    9.2 Latin America Gene Therapies for Cancer Treatment Market Size by Type
        9.2.1 Latin America Gene Therapies for Cancer Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Gene Therapies for Cancer Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Gene Therapies for Cancer Treatment Market Size by Type (2016-2027)
    9.3 Latin America Gene Therapies for Cancer Treatment Market Size by Application
        9.3.1 Latin America Gene Therapies for Cancer Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Gene Therapies for Cancer Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Gene Therapies for Cancer Treatment Market Size by Application (2016-2027)
    9.4 Latin America Gene Therapies for Cancer Treatment Market Size by Country
        9.4.1 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type
        10.2.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application
        10.3.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country
        10.4.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Takara Bio
        11.1.1 Takara Bio Company Details
        11.1.2 Takara Bio Business Overview
        11.1.3 Takara Bio Gene Therapies for Cancer Treatment Introduction
        11.1.4 Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.1.5 Takara Bio Recent Development
    11.2 Tocagen
        11.2.1 Tocagen Company Details
        11.2.2 Tocagen Business Overview
        11.2.3 Tocagen Gene Therapies for Cancer Treatment Introduction
        11.2.4 Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.2.5 Tocagen Recent Development
    11.3 VBL Therapeutics
        11.3.1 VBL Therapeutics Company Details
        11.3.2 VBL Therapeutics Business Overview
        11.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Introduction
        11.3.4 VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.3.5 VBL Therapeutics Recent Development
    11.4 Cold Genesys
        11.4.1 Cold Genesys Company Details
        11.4.2 Cold Genesys Business Overview
        11.4.3 Cold Genesys Gene Therapies for Cancer Treatment Introduction
        11.4.4 Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.4.5 Cold Genesys Recent Development
    11.5 Genprex
        11.5.1 Genprex Company Details
        11.5.2 Genprex Business Overview
        11.5.3 Genprex Gene Therapies for Cancer Treatment Introduction
        11.5.4 Genprex Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.5.5 Genprex Recent Development
    11.6 Momotaro-Gene
        11.6.1 Momotaro-Gene Company Details
        11.6.2 Momotaro-Gene Business Overview
        11.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Introduction
        11.6.4 Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.6.5 Momotaro-Gene Recent Development
    11.7 MultiVir
        11.7.1 MultiVir Company Details
        11.7.2 MultiVir Business Overview
        11.7.3 MultiVir Gene Therapies for Cancer Treatment Introduction
        11.7.4 MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.7.5 MultiVir Recent Development
    11.8 SynerGene Therapeutics
        11.8.1 SynerGene Therapeutics Company Details
        11.8.2 SynerGene Therapeutics Business Overview
        11.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Introduction
        11.8.4 SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.8.5 SynerGene Therapeutics Recent Development
    11.9 Ziopharm Oncology
        11.9.1 Ziopharm Oncology Company Details
        11.9.2 Ziopharm Oncology Business Overview
        11.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Introduction
        11.9.4 Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.9.5 Ziopharm Oncology Recent Development
    11.10 Anchiano Therapeutics
        11.10.1 Anchiano Therapeutics Company Details
        11.10.2 Anchiano Therapeutics Business Overview
        11.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Introduction
        11.10.4 Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.10.5 Anchiano Therapeutics Recent Development
    11.11 Celgene
        11.11.1 Celgene Company Details
        11.11.2 Celgene Business Overview
        11.11.3 Celgene Gene Therapies for Cancer Treatment Introduction
        11.11.4 Celgene Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.11.5 Celgene Recent Development
    11.12 Celsion
        11.12.1 Celsion Company Details
        11.12.2 Celsion Business Overview
        11.12.3 Celsion Gene Therapies for Cancer Treatment Introduction
        11.12.4 Celsion Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.12.5 Celsion Recent Development
    11.13 Bluebird Bio
        11.13.1 Bluebird Bio Company Details
        11.13.2 Bluebird Bio Business Overview
        11.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Introduction
        11.13.4 Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2016-2021)
        11.13.5 Bluebird Bio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Somatic Cell Gene Therapy (SCGT) Table 3. Key Players of Germline Gene Therapy (GGT) Table 4. Global Gene Therapies for Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Gene Therapies for Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Gene Therapies for Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Gene Therapies for Cancer Treatment Market Share by Regions (2016-2021) Table 8. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Gene Therapies for Cancer Treatment Market Share by Regions (2022-2027) Table 10. Gene Therapies for Cancer Treatment Market Trends Table 11. Gene Therapies for Cancer Treatment Market Drivers Table 12. Gene Therapies for Cancer Treatment Market Challenges Table 13. Gene Therapies for Cancer Treatment Market Restraints Table 14. Global Gene Therapies for Cancer Treatment Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Gene Therapies for Cancer Treatment Market Share by Players (2016-2021) Table 16. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapies for Cancer Treatment as of 2020) Table 17. Ranking of Global Top Gene Therapies for Cancer Treatment Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Gene Therapies for Cancer Treatment Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Gene Therapies for Cancer Treatment Product Solution and Service Table 21. Date of Enter into Gene Therapies for Cancer Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Gene Therapies for Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 24. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2016-2021) Table 25. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Gene Therapies for Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2016-2021) Table 29. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Gene Therapies for Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 32. North America Gene Therapies for Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Gene Therapies for Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 34. North America Gene Therapies for Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Gene Therapies for Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Gene Therapies for Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Gene Therapies for Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Gene Therapies for Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Gene Therapies for Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Gene Therapies for Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Gene Therapies for Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Gene Therapies for Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Gene Therapies for Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Gene Therapies for Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Gene Therapies for Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Gene Therapies for Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Gene Therapies for Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Gene Therapies for Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 61. Takara Bio Company Details Table 62. Takara Bio Business Overview Table 63. Takara Bio Gene Therapies for Cancer Treatment Product Table 64. Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million) Table 65. Takara Bio Recent Development Table 66. Tocagen Company Details Table 67. Tocagen Business Overview Table 68. Tocagen Gene Therapies for Cancer Treatment Product Table 69. Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million) Table 70. Tocagen Recent Development Table 71. VBL Therapeutics Company Details Table 72. VBL Therapeutics Business Overview Table 73. VBL Therapeutics Gene Therapies for Cancer Treatment Product Table 74. VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million) Table 75. VBL Therapeutics Recent Development Table 76. Cold Genesys Company Details Table 77. Cold Genesys Business Overview Table 78. Cold Genesys Gene Therapies for Cancer Treatment Product Table 79. Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million) Table 80. Cold Genesys Recent Development Table 81. Genprex Company Details Table 82. Genprex Business Overview Table 83. Genprex Gene Therapies for Cancer Treatment Product Table 84. Genprex Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million) Table 85. Genprex Recent Development Table 86. Momotaro-Gene Company Details Table 87. Momotaro-Gene Business Overview Table 88. Momotaro-Gene Gene Therapies for Cancer Treatment Product Table 89. Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million) Table 90. Momotaro-Gene Recent Development Table 91. MultiVir Company Details Table 92. MultiVir Business Overview Table 93. MultiVir Gene Therapies for Cancer Treatment Product Table 94. MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million) Table 95. MultiVir Recent Development Table 96. SynerGene Therapeutics Company Details Table 97. SynerGene Therapeutics Business Overview Table 98. SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million) Table 99. SynerGene Therapeutics Recent Development Table 100. Ziopharm Oncology Company Details Table 101. Ziopharm Oncology Business Overview Table 102. Ziopharm Oncology Gene Therapies for Cancer Treatment Product Table 103. Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million) Table 104. Ziopharm Oncology Recent Development Table 105. Anchiano Therapeutics Company Details Table 106. Anchiano Therapeutics Business Overview Table 107. Anchiano Therapeutics Gene Therapies for Cancer Treatment Product Table 108. Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million) Table 109. Anchiano Therapeutics Recent Development Table 110. Celgene Company Details Table 111. Celgene Business Overview Table 112. Celgene Gene Therapies for Cancer Treatment Product Table 113. Celgene Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million) Table 114. Celgene Recent Development Table 115. Celsion Company Details Table 116. Celsion Business Overview Table 117. Celsion Gene Therapies for Cancer Treatment Product Table 118. Celsion Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million) Table 119. Celsion Recent Development Table 120. Bluebird Bio Company Details Table 121. Bluebird Bio Business Overview Table 122. Bluebird Bio Gene Therapies for Cancer Treatment Product Table 123. Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2016-2021) & (US$ Million) Table 124. Bluebird Bio Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global Gene Therapies for Cancer Treatment Market Share by Type: 2020 VS 2027 Figure 2. Somatic Cell Gene Therapy (SCGT) Features Figure 3. Germline Gene Therapy (GGT) Features Figure 4. Global Gene Therapies for Cancer Treatment Market Share by Application: 2020 VS 2027 Figure 5. Cancer Research Centers Case Studies Figure 6. Diagnostic Laboratories Case Studies Figure 7. Cancer Hospitals Case Studies Figure 8. Others Case Studies Figure 9. Gene Therapies for Cancer Treatment Report Years Considered Figure 10. Global Gene Therapies for Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Gene Therapies for Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Gene Therapies for Cancer Treatment Market Share by Regions: 2020 VS 2027 Figure 13. Global Gene Therapies for Cancer Treatment Market Share by Regions (2022-2027) Figure 14. Global Gene Therapies for Cancer Treatment Market Share by Players in 2020 Figure 15. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapies for Cancer Treatment as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Gene Therapies for Cancer Treatment Revenue in 2020 Figure 17. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2016-2021) Figure 18. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2022-2027) Figure 19. North America Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Gene Therapies for Cancer Treatment Market Share by Type (2016-2027) Figure 21. North America Gene Therapies for Cancer Treatment Market Share by Application (2016-2027) Figure 22. North America Gene Therapies for Cancer Treatment Market Share by Country (2016-2027) Figure 23. United States Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Gene Therapies for Cancer Treatment Market Share by Type (2016-2027) Figure 27. Europe Gene Therapies for Cancer Treatment Market Share by Application (2016-2027) Figure 28. Europe Gene Therapies for Cancer Treatment Market Share by Country (2016-2027) Figure 29. Germany Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Gene Therapies for Cancer Treatment Market Share by Type (2016-2027) Figure 37. Asia-Pacific Gene Therapies for Cancer Treatment Market Share by Application (2016-2027) Figure 38. Asia-Pacific Gene Therapies for Cancer Treatment Market Share by Region (2016-2027) Figure 39. China Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Gene Therapies for Cancer Treatment Market Share by Type (2016-2027) Figure 47. Latin America Gene Therapies for Cancer Treatment Market Share by Application (2016-2027) Figure 48. Latin America Gene Therapies for Cancer Treatment Market Share by Country (2016-2027) Figure 49. Mexico Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Gene Therapies for Cancer Treatment Market Share by Type (2016-2027) Figure 53. Middle East & Africa Gene Therapies for Cancer Treatment Market Share by Application (2016-2027) Figure 54. Middle East & Africa Gene Therapies for Cancer Treatment Market Share by Country (2016-2027) Figure 55. Turkey Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Gene Therapies for Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Takara Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021) Figure 59. Tocagen Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021) Figure 60. VBL Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021) Figure 61. Cold Genesys Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021) Figure 62. Genprex Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021) Figure 63. Momotaro-Gene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021) Figure 64. MultiVir Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021) Figure 65. SynerGene Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021) Figure 66. Ziopharm Oncology Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021) Figure 67. Anchiano Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021) Figure 68. Celgene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021) Figure 69. Celsion Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021) Figure 70. Bluebird Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us